BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/22/2022 8:29:42 AM | Browse: 321 | Download: 802
 |
Received |
|
2021-04-25 13:38 |
|
Peer-Review Started |
|
2021-04-25 13:41 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-07 00:57 |
|
Revised |
|
2021-06-24 02:12 |
|
Second Decision |
|
2022-05-11 03:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-05-12 20:07 |
|
Articles in Press |
|
2022-05-12 20:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-05-09 23:10 |
|
Typeset the Manuscript |
|
2022-05-26 06:30 |
|
Publish the Manuscript Online |
|
2022-06-22 08:29 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Current treatment landscape for oligometastatic non-small cell lung cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Javier Garde-Noguera, Margarita Martín-Martín, Andres Obeso, Miriam López-Mata, Inigo Royo Crespo, Lira Pelari-Mici, Oscar Juan Vidal, Xabier Mielgo-Rubio, Juan Carlos Trujillo-Reyes and Felipe Couñago |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Javier Garde-Noguera, MD, Consultant Physician-Scientist, Department of Medical Oncology, Hospital Arnau de Vilanova, Carrer de Sant Clement, 12, Valencia 46015, Spain. javiergardenoguera1@gmail.com |
| Key Words |
Oligometastatic; Non-small cell lung carcinoma; Non-small cell lung cancer; Oligometastasis |
| Core Tip |
The treatment of oligometastatic non-small cell lung cancer patients remains controversial. The lack of solid evidence for the best therapeutic strategy and the multiple options currently available for both systemic and local treatments make this particular population of patients a challenge for clinicians. Improvement of surgical and radiotherapy techniques and the appearance of different ablative methods, such as radiofrequency or cryoablation, have made it possible to radically treat metastases in any location. In addition, recent prospective studies suggest that combining these ablative therapies with systemic treatments improve patient outcomes. We discuss the current status of the management of oligometastatic patients. |
| Publish Date |
2022-06-22 08:29 |
| Citation |
Garde-Noguera J, Martín-Martín M, Obeso A, López-Mata M, Royo Crespo I, Pelari-Mici L, Juan Vidal O, Mielgo-Rubio X, Trujillo-Reyes JC, Couñago F. Current treatment landscape for oligometastatic non-small cell lung cancer. World J Clin Oncol 2022; 13(6): 485-495 |
| URL |
https://www.wjgnet.com/2218-4333/full/v13/i6/485.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v13.i6.485 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
